People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Pharma, Other Health Care, Pharmaceuticals, Biotechnology, Other Technology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pear Therapeutics, Inc. | — | Pharma | Series D+ | $254.8M | $4.1B | 2017 |
| TMRW Life Sciences, Inc. | — | Other Health Care | Series D+ | $184.8M | $284.2M | 2021 |
| Nemus Bioscience, Inc. | — | Pharmaceuticals | Series C | $168.4M | $388.7M | 2023 |
| Escient Pharmaceuticals Inc | — | Biotechnology | Series C | $108.8M | $995.9M | 2018 |
| Purigen Biosystems, Inc. | — | Biotechnology | Series B | $61.9M | $1.4B | 2016 |
| Radionetics Oncology, Inc. | — | Pharmaceuticals | Series C | $54.2M | $652.4M | 2023 |
| Flexion Therapeutics Inc | — | Biotechnology | Series B | $40.0M | $793.8M | 2012 |
| Cleave Biosciences, Inc. | — | Biotechnology | Series B | $37.9M | $475.1M | 2016 |
| Assay Depot Inc | — | Other Technology | Series B | $37.0M | $72.3M | 2019 |
| Nido Biosciences, Inc. | — | Biotech / Pharma | Series B | $22.4M | $637.1M | 2019 |
| Ride Health, Inc. | — | Healthtech | Series B | $21.5M | $93.3M | 2024 |
| BEKHealth Corp | — | Other Technology | Series A | $15.3M | $18.4M | 2021 |
| Huma.AI, Inc. | — | AI / ML | Series A | $15.0M | $4.4M | 2022 |
| Itiliti Health, Inc. | — | Healthtech | Seed | $6.2M | $2.1M | 2022 |
| Viveve, Inc. | — | Other | Seed | $5.5M | $74.4M | 2009 |
| S2N Health Inc. | — | Healthtech | Series A | $4.5M | $22.8M | 2024 |
Andrew Schwab at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Schwab on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Crumpler | 2 | 7 |
| Steve Skolsky | 2 | 4 |
| Jonathan Root | 1 | 16 |
| Peter Thompson | 1 | 16 |
| Todd Pietri | 1 | 13 |
| ALAN MURRAY | 1 | 12 |
| Landon Gibbs | 1 | 12 |
| BRADLEY BOLZON | 1 | 10 |
| Heath Lukatch | 1 | 10 |
| Devin Carty | 1 | 10 |
| Timothy Petersen | 1 | 9 |
| WILLIAM DAI | 1 | 8 |
| Annalisa Jenkins | 1 | 8 |
| David Levin | 1 | 7 |
| Peter Hirth | 1 | 7 |
| Jared Kesselheim | 1 | 7 |
| Andrew J. Schwab | 1 | 7 |
| Elaine Jones | 1 | 6 |
| Jason Hafler | 1 | 6 |
| Carol Gallagher | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.